SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524636

INE102E01018

-9.9177201

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

200.97

EPS(TTM)

Face Value()

Div & Yield %

Back

Refex Industries consolidated net profit rises 7.73% in the December 2025 quarter

Jan 21,2026

Net profit of Refex Industries rose 7.73% to Rs 53.92 crore in the quarter ended December 2025 as against Rs 50.05 crore during the previous quarter ended December 2024. Sales declined 16.04% to Rs 576.01 crore in the quarter ended December 2025 as against Rs 686.04 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	576.01	686.04	-16
OPM %	15.58	7.75	-
PBDT	86.41	73.01	18
PBT	81.37	70.38	16
NP	53.92	50.05	8

76,913.50 -582.86 ( -0.75%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)